GO
Loading...

GlaxoSmithKline PLC

More

  • Spotlight on Glaxo Heart Drug as Others Fail Thursday, 12 Apr 2007 | 10:24 AM ET

    The failure of rival heart drugs has put the spotlight on a novel GlaxoSmithKline compound that will reach a critical stage of testing this year, after languishing in development for years.

  • MSNBC Drops Don Imus Radio Simulcast Thursday, 12 Apr 2007 | 9:21 AM ET
    Radio personality Don Imus appears on Rev.Al Sharpton's radio show, in New York Monday April 9, 2007. Imus issued another apology for referring to the Rutgers women's basketball team as "nappy-headed hos" on his morning show last week. (AP Photo/Richard Drew)

    NBC News has decided that its cable news channel, MSNBC will no longer simulcast the Don Imus radio program, effective immediately.  CBS Radio says its two week suspension of the program stands although it is monitoring the situation.  Advertisers have been defecting from the controversial radio host.

  • CNBC's Deutsch: "I Think Imus Is Done" Wednesday, 11 Apr 2007 | 3:00 PM ET

    The storm over Don Imus' racial comments escalated as more advertisers pulled out from his show. CNBC's Donny Deutsch told "Power Lunch" that "I think Imus is done."

  • An experimental bowel drug from GlaxoSmithKline and its partner Adolor has little commercial future following safety problems that caused trials to be put on hold, analysts said on Tuesday.

  • It's Time for the Lightning Round! Monday, 9 Apr 2007 | 8:37 PM ET

    It was an extra-long Lightning Round today. So that means Cramer covered everything from retail to tech to banks to agriculture -- and more.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • Biopharmaceutical company Theravance Inc. said Monday it saw positive results from two midstage studies dealing with its developing asthma and chronic obstructive pulmonary disease treatments.

  • GlaxoSmithKline  said Thursday it has submitted a biologics license application for Cervarix, its cervical cancer candidate vaccine, to the U.S. Food and Drug Administration.

  • Boehringer's 2006 Net Rises, Will Stay Independent Tuesday, 27 Mar 2007 | 10:39 AM ET
  • March Madness is Here: Who Will Profit? Thursday, 15 Mar 2007 | 11:17 AM ET

    Last night I debated John Challenger of Challenger, Gray and Christmas, the firm that each year comes out with that March Madness lost wages study.

  • U.S. health regulators have approved GlaxoSmithKline's pill Tykerb for patients with advanced breast cancer after other treatments have failed, a company spokeswoman said on Tuesday.

  • J.P. Garnier, GlaxoSmithKline's chief executive officer, told CNBC's "Squawk Box" Wednesday that he expects to make the company's new drug for advanced breast cancer available to U.S. patients "within a few days."

  • Drugmaker Schering-Plough is buying Organon Biosciences for about $14.5 billion. Organon is part of the Dutch paint and chemical company Akzo Nobel whose shares are at a new high today on the news. Schering Chairman and CEO Fred Hassan has been saying for quite some time that he's "very much in the deal flow" on company conference calls and in interviews with CNBC, so the fact that he's making a big acquisition doesn't come as a huge shock.

  • Genentech Shares Fall on Avastin Pricing Fears Thursday, 22 Feb 2007 | 12:27 PM ET

    Genentech shares traded lower after data from a clinical trial indicated that a lower dosage of the blockbuster cancer drug Avastin was as effective as the standard dose for lung cancer patients.

  • A new study may provide hope for the tens of millions of Americans who have chronic obstructive pulmonary disease or COPD.

  • Drugmaker Merck said it would stop lobbying state legislatures to make it mandatory for schoolgirls to be inoculated with its new cervical cancer vaccine.

  • GlaxoSmithKline Posts 16% Rise in Full-Year Profit Thursday, 8 Feb 2007 | 8:08 AM ET

    GlaxoSmithKline, Europe's biggest drug maker, reported a 16% rise in annual profit Thursday, in line with expectations of analysts polled by Reuters. But the company said 2007 growth would slow as it awaits pipeline renewal.

  • Gardasil: On Guard Tuesday, 6 Feb 2007 | 10:54 AM ET

    The Governor of Texas announced on Friday that all girls entering the sixth grade in his state must get Merck's new vaccine, Gardasil, before they can enroll. Gardasil prevents four strains of the sexually-transmitted disease known as HPV which is the leading cause of cervical cancer. It works best when given before becoming sexually active. But the political and social backlash has already begun.

  • Potent Growth in Impotence Drug Market Friday, 19 Jan 2007 | 12:51 PM ET

    The Eli Lilly-Icos joint venture reported that worldwide sales of their erectile dysfunction drug came to $971 million last year -- and is now on the cusp of becoming a billion-dollar blockbuster drug in 2007.  We will find out how Viagra is doing when Pfizer reports earnings before the bell on Monday morning, but sales growth is expected to have picked up.  These results represent a significant turnaround in a drug segment that some thought had already had its day.

  • You’ll find some of the most influential figures in modern healthcare in San Francisco today, gathered together for the 25th Annual J.P. Morgan Healthcare Conference.  This year, 6500 people are attending, including CNBC’s Mike Huckman who is sifting through volumes of data. In a  "First on CNBC,"  Huckman spoke with James Sabry, M.D./Ph. D., the CEO of Cytokinetics. 

  • Glaxo Breast Cancer Drug Shows Promise, Study Says Thursday, 28 Dec 2006 | 7:34 AM ET

    A study being published in a major medical journal confirms the promise of a breast cancer drug from GlaxoSmithKline that's awaiting the approval of the Food and Drug Administration, CNBC's Mike Huckman reports.

Most Popular Video

Wednesday, 16 Apr 2014 | 12:00 AM ET

GM unveils new models, hopes for strong sales this year After massive recalls, General Motors is pushing forward with new car models unveiled at the 2014 New York International Auto Show. CNBC's Phil LeBeau explains.

Friday, 11 Apr 2014 | 7:23 AM ET

Former Fed Chairman Ben Bernanke challenges Raghuram Rajan, Reserve Bank of India governor on his views about monetary policies, reports CNBC's Michelle Caruso-Cabrera.

Tuesday, 15 Apr 2014 | 5:40 PM ET

Jonathan Geller, BGR president and editor-in-chief, weighs in on the specifications for Amazon's newly announced 3-D smartphone.